Summary
Updated Aug 31, 2026
Mark A. Kronenfeld is Director of Pacira BioSciences, Inc. (PCRX). 1 SEC Form 4 filing on record, dated 19 March 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Mark A. Kronenfeld has reported, most recent first.
Trading Pattern
InsiderAlpha's records for Mark A. Kronenfeld go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Mark A. Kronenfeld files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shawn Cross - $895K of PCRX open-market activity in the last 12 months
- Kristen Williams - $498K of PCRX open-market activity in the last 12 months
- Jonathan Slonin - $240K of PCRX open-market activity in the last 12 months
- Lauren Riker - $227K of PCRX open-market activity in the last 12 months
- Abraham Ceesay - $64K of PCRX open-market activity in the last 12 months
- Mark Froimson - $11K of PCRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Mark A. Kronenfeld?
Mark A. Kronenfeld is a corporate insider, tracked as Director of Pacira BioSciences, Inc. (PCRX). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Mark A. Kronenfeld last file a Form 4?
The only primary Form 4 on record is dated 19 March 2026.
Where can I see all of Mark A. Kronenfeld's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Mark A. Kronenfeld and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial